Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes: A randomized clinical trial

Sexually Transmitted Diseases

Volumn 24, Issue 5, 1997, Pages 279-283

  Martin Jr , Harold L ^a   Stevens, Claire E ^a   Richardson, Barbra A ^a   Rugamba, Daphne ^a   Nyange, Patrick M ^b   Mandaliya, Kishorchandra ^c   Ndinya Achola, Jeckoniah ^b   Kreiss, Joan K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c Department of Obstetrics and Gynaecology   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANTAGE 24; NONOXINOL 9; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PROSTITUTION; RANDOMIZED CONTROLLED TRIAL; SEXUALLY TRANSMITTED DISEASE; TREATMENT OUTCOME;

EID: 0342711187     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199705000-00008     Document Type: Article

References (11)

1. Hicks DR, Martin LS, Getchell JP, et al. Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro [letter]. Lancet 1985; 2:1422-1423.
2. Polsky B, Baron PA, Gold JWM, Smith JL, Jensen RH, Armstrong D. In vitro inactivation of HIV-1 by contraceptive sponge containing nonoxynol-9 [letter]. Lancet 1988; 1:1456.
3. Kreiss J, Ngugi E, Holmes K, et al. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992; 268:477-482.
4. Zekeng L, Feldblum PJ, Oliver RM, Kaptue L. Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS 1993; 7:725-731.
5. Feldblum PJ, Weir SS. The protective effect of nonoxynol-9 against HIV infection [letter]. Am J Public Health 1994; 84:890-891.
6. Niruthisard S, Roddy RE, Chutivongse S. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex Transm Dis 1991; 18:176-179.
7. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS 1993; 4:165-170.
8. Martin H, Jackson D, Mandaliya K, et al. Preparation for AIDS vaccine evaluation in Mombasa, Kenya: Establishment of seronegative cohorts of commercial sex workers and trucking company employees. AIDS Res Human Retroviruses 1994; 10: S235-S237.
9. World Health Organization. Manual for the Standardization of Colposcopy for the Evaluation of Vaginally Administered Products. Geneva: World Health Organization, November, 1993.
10. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42:121-130.
11. Poindexter AN, Levine H, Sangi-Haghpeykar H, Frank ML, Grear A, Reeves KO. Comparison of spermicides on vulvar, vaginal, and cervical mucosa. Contraception 1996; 53:147-153.